https://www.dovepress.com/a-pilot-study-of-04-povidone-iodine-nasal-spray-to-eradicate-sars-cov--peer-reviewed-fulltext-article-IDR
0
0
12/20/22 at 12:37pm
Organization
Dovepress.com
Author
Dove Press
Evaluatig the virucidal efficacy of 0.4% povidone-iodine nasal spray against SARS-CoV-2 in the patients’ nasopharynx at 3 minutes, 4 hours after PVP-I exposure.
Create an account
or login to join the discussion